Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (321-330 of 682) with videos related to

Pageof 69
Sort By:
International Journal of Antimicrobial Agents|November 26, 2018
Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic reviewAaron J Heffernan, Fekade B Sime, Jeffrey Lipman, et al.
Medicine|June 4, 2021
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainmentUte Chiriac, Otto R Frey, Anka C Roehr, et al.
International Journal of Antimicrobial Agents|July 6, 2024
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaEmanuele Rando, Emmanuel Novy, Flavio Sangiorgi, et al.
Critical Care Medicine|April 19, 2012
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic studyDarren M Roberts, Jason A Roberts, Michael S Roberts, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2026
Therapeutic drug monitoring and the role of pharmacokinetics/pharmacodynamics in optimizing beta-lactam antibiotic dosing for deep-seated infections: a systematic reviewCassandra Vale, Fekade B Sime, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2021
Population Pharmacokinetics of Intraperitoneal Gentamicin and the Impact of Varying Dwell Times on Pharmacodynamic Target Attainment in Patients with Acute Peritonitis Undergoing Peritoneal DialysisAndras Farkas, Katerina Oikonomou, Mohammad Ghanbar, et al.
Clinical Pharmacokinetics|September 1, 2019
Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency DialysisSalmaan Kanji, Jason A Roberts, Jiao Xie, et al.
BMC Anesthesiology|February 24, 2011
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Mahdi Altukroni, Andrew A Udy, et al.
Critical Care (London, England)|December 16, 2015
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine modelsKiran Shekar, Jason A Roberts, Adrian G Barnett, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Pharmacokinetics of Intravenous Posaconazole in Critically Ill PatientsFekade B Sime, Janine Stuart, Jenie Butler, et al.
Pageof 69

Showing results (321-330 of 682) with videos related to

Sort By:
Pageof 69
International Journal of Antimicrobial Agents|November 26, 2018
Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic reviewAaron J Heffernan, Fekade B Sime, Jeffrey Lipman, et al.
Medicine|June 4, 2021
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainmentUte Chiriac, Otto R Frey, Anka C Roehr, et al.
International Journal of Antimicrobial Agents|July 6, 2024
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaEmanuele Rando, Emmanuel Novy, Flavio Sangiorgi, et al.
Critical Care Medicine|April 19, 2012
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic studyDarren M Roberts, Jason A Roberts, Michael S Roberts, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2026
Therapeutic drug monitoring and the role of pharmacokinetics/pharmacodynamics in optimizing beta-lactam antibiotic dosing for deep-seated infections: a systematic reviewCassandra Vale, Fekade B Sime, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2021
Population Pharmacokinetics of Intraperitoneal Gentamicin and the Impact of Varying Dwell Times on Pharmacodynamic Target Attainment in Patients with Acute Peritonitis Undergoing Peritoneal DialysisAndras Farkas, Katerina Oikonomou, Mohammad Ghanbar, et al.
Clinical Pharmacokinetics|September 1, 2019
Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency DialysisSalmaan Kanji, Jason A Roberts, Jiao Xie, et al.
BMC Anesthesiology|February 24, 2011
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Mahdi Altukroni, Andrew A Udy, et al.
Critical Care (London, England)|December 16, 2015
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine modelsKiran Shekar, Jason A Roberts, Adrian G Barnett, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Pharmacokinetics of Intravenous Posaconazole in Critically Ill PatientsFekade B Sime, Janine Stuart, Jenie Butler, et al.
Pageof 69